AI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks ⁠off these labor-intensive processes, seven large drugmakers and six smaller biotech ...

Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it is already streamlining less ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...

For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...

Scientists have developed a new treatment strategy that could one day save the lives of children affected by aggressive brain ...